GAS5-knockdown by tail vein injection of lentivirus containing shGAS5 led to GAS5 inhibition in the livers of HFD mice, accompanied with improved liver steatosis and reduced serum levels of ALT, AST, TCHO and triacylglycerol. Here, GAS5 is linked to fatty liver disease.